Skip to content
  • Home
  • Identity
  • Our Services
  • Countries presence
  • News
  • Contact Us

Day: 26 September 2022

  1. Home
  2. Archives: September 2022

Randomized Assessment of the Safety and Efficacy of Intra-Arterial Infusion of Autologous Stem Cells in Subacute Ischemic Stroke

stem-cells-ictus-therapy

Stroke is a debilitating illness for which treatment window is limited. Most patients present to the healthcare facility beyond that window.

Continue reading
biobank Cord blood cord blood stem cells Stem cells Swiss stem cells Swiss stem cells biotech

Recent Posts

  • Progress in clinical trials of stem cell therapy for cerebral palsy
  • Stem cells: are we ready for therapy?
  • Stemedica announces clinical trial for IV stem cell treatment for chronic ischemic stroke
  • Stem Cell Therapy: A Promising Therapeutic Method for Intracerebral Hemorrhage
  • Kamsiyochukwu Cured of Sickle Cell by Cord Blood Transplant

Recent Comments

No comments to show.
Linkedin
  • Home
  • Identity
  • Our Services
  • Countries presence
  • News
  • Contact Us
  • Home
  • Identity
  • Our Services
  • Countries presence
  • News
  • Contact Us

©2022 Swiss Stem Cells Biotech SA – P.IVA CH277426754